TCIM
NYMX

TIAA CREF Investment Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

TIAA CREF Investment Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-77,336
Closed -$255K – 3076
2017
Q4 		$255K Hold
77,336
– – ﹤0.01% 2971
2017
Q3 		$295K Buy
77,336
+2,591
+3% +$9.82K ﹤0.01% 2997
2017
Q2 		$329K Buy
+74,745
New +$307K ﹤0.01% 3019

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TIAA CREF Investment Management's NYMX Position: Q1 2018 in Review

TIAA CREF Investment Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2018, closing a stake of 77,336 shares — an estimated $255K sold.

TIAA CREF Investment Management first reported a position in NYMX in Q2 2017 and held it in 3 quarters. The position peaked at $329K in Q2 2017. 48 funds tracked by Wall St. Rank hold NYMX as of Q1 2018.

  • TIAA CREF Investment Management reported no remaining Nymox Pharmaceutical Corp position as of Q1 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 77,336 Nymox Pharmaceutical Corp shares in Q1 2018, an estimated $255K.
  • TIAA CREF Investment Management first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 3 quarters.
  • TIAA CREF Investment Management's Nymox Pharmaceutical Corp position peaked at $329K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2018.

Based on TIAA CREF Investment Management's 13F filing for Q1 2018, filed 14 May 2018.